Results 151 to 160 of about 9,635 (207)

Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulating Therapies on Liver Transplant Outcomes. [PDF]

Gastro Hep Adv
Naimimohasses S, Ray A, Tan E, Wiggins A, Hasjim BJ, Chen S, Bhat M.   +6 more
europepmc   +1 more source

Home sputum collection for <i>Aspergillus fumigatus</i> detection in adults with cystic fibrosis. [PDF]

ERJ Open Res
Hong G, Walsh J, Koshy A, Hsu JY, O'Dea AL, Vesely EM, Memon W, Dezube RH, Goss CH, Goss LB, Greene A, Gross JE, Wilson A, Nichols DP, Zhang SX, Cramer RA.   +15 more
europepmc   +1 more source

Effects of cAMP and CFTR modulation on apical fluid pH in human airway Calu-3 cells. [PDF]

Physiol Rep
Nguyen JP, Milad N, Hirota JA.
europepmc   +1 more source

Aging Gracefully: Does Elexacaftor/Tezacaftor/Ivacaftor Safety and Efficacy Stand the Test of Time? [PDF]

Am J Respir Crit Care Med
Wilson G, Hughes D.
europepmc   +1 more source

An alternative view of changes in lung function among people with cystic fibrosis. [PDF]

J Cyst Fibros
McElvaney OJ, Goss CH.
europepmc   +1 more source

Systemic and airway T cell dynamics with influenza-specific immune recovery by cystic fibrosis elexacaftor/tezacaftor/ivacaftor therapy. [PDF]

Respir Res
Mouchtaridi E, Kowalik A, Raineri EJM, Humbert M, Jägerstedt J, Bojarlind M, Nilsson K, Flodström-Tullberg M, Pincikova T, Sandberg JK.   +9 more
europepmc   +1 more source

Top 10 drugs 2024-25. [PDF]

Aust Prescr
europepmc   +1 more source